doi:10.1016/s0001-7310(06)73466-4 [73] Vitamin C
Looking ahead, the combination of ePA with other digital health trends could reshape GLP-1 management: Telehealth and Remote Initiation: If a patient sees a telehealth obesity specialist via video, that provider could use ePA to prescribe GLP-1 and get real-time approval without requiring an in-person follow-up for signature
Pomalyst (pomalidomide) Disease area(s): Oncology/hematology Manufacturer(s): Bristol Myers Squibb 2024 Sales (USD): $3.55 billion Why it sold so well: Bristol Myers Squibbs blood cancer drug Pomalyst netted global sales of $3.55 billion, an increase of 3% from the previous year and accounted for approximately 7.3% of the companys total revenue of $48.3 billion in 2024
in trials without prespecified kidney endpoints, renal findings are derived from secondary, post hoc , or safety analyses
Chen will interview participants at the VA Connecticut Healthcare System (VACHS) before they begin the medication to collect information about their quality of life, including physical function, mood, pain, and expectations for the trial